24 February 2015 - The Biosafety Council issues a positive advice (with conditions) for this trialFile: b-be-14-bvw1-advice-biosafety-council.pdfTrial reference: A phase 2 clinical trial with Talimogene LaherparepvecDoc type: Information related to the decision procedure
